Literature DB >> 18266915

Membrane traffic and muscle: lessons from human disease.

James J Dowling1, Elizabeth M Gibbs, Eva L Feldman.   

Abstract

Like all mammalian tissues, skeletal muscle is dependent on membrane traffic for proper development and homeostasis. This fact is underscored by the observation that several human diseases of the skeletal muscle are caused by mutations in gene products of the membrane trafficking machinery. An examination of these diseases and the proteins that underlie them is instructive both in terms of determining disease pathogenesis and of understanding the normal aspects of muscle biology regulated by membrane traffic. This review highlights our current understanding of the trafficking genes responsible for human myopathies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18266915      PMCID: PMC2935664          DOI: 10.1111/j.1600-0854.2008.00716.x

Source DB:  PubMed          Journal:  Traffic        ISSN: 1398-9219            Impact factor:   6.215


  67 in total

Review 1.  Regulating actin dynamics at membranes: a focus on dynamin.

Authors:  Dorothy A Schafer
Journal:  Traffic       Date:  2004-07       Impact factor: 6.215

2.  118th ENMC International Workshop on Advances in Myotubular Myopathy. 26-28 September 2003, Naarden, The Netherlands. (5th Workshop of the International Consortium on Myotubular Myopathy).

Authors:  E Bertini; V Biancalana; A Bolino; A Buj Bello; M Clague; P Guicheney; H Jungbluth; W Kress; A Musaro'; H Nandurkar; L Pirola; N Romero; J Senderek; U Suter; C Sewry; H Tronchere; C Wallgren-Pettersson; M J Wishart; J Laporte
Journal:  Neuromuscul Disord       Date:  2004-06       Impact factor: 4.296

Review 3.  Dynamin as a mover and pincher during cell migration and invasion.

Authors:  Anne E Kruchten; Mark A McNiven
Journal:  J Cell Sci       Date:  2006-05-01       Impact factor: 5.285

Review 4.  The dynamins: redundant or distinct functions for an expanding family of related GTPases?

Authors:  R Urrutia; J R Henley; T Cook; M A McNiven
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-21       Impact factor: 11.205

5.  FER-1 regulates Ca2+ -mediated membrane fusion during C. elegans spermatogenesis.

Authors:  Nicole L Washington; Samuel Ward
Journal:  J Cell Sci       Date:  2006-05-30       Impact factor: 5.285

6.  Expression of caveolin-3 in skeletal, cardiac, and smooth muscle cells. Caveolin-3 is a component of the sarcolemma and co-fractionates with dystrophin and dystrophin-associated glycoproteins.

Authors:  K S Song; P E Scherer; Z Tang; T Okamoto; S Li; M Chafel; C Chu; D S Kohtz; M P Lisanti
Journal:  J Biol Chem       Date:  1996-06-21       Impact factor: 5.157

7.  Characterization of the muscle involvement in dynamin 2-related centronuclear myopathy.

Authors:  Dirk Fischer; Muriel Herasse; Marc Bitoun; Héctor M Barragán-Campos; Jacques Chiras; Pascal Laforêt; Michel Fardeau; Bruno Eymard; Pascale Guicheney; Norma B Romero
Journal:  Brain       Date:  2006-04-03       Impact factor: 13.501

8.  Changes in architecture of the Golgi complex and other subcellular organelles during myogenesis.

Authors:  E Ralston
Journal:  J Cell Biol       Date:  1993-01       Impact factor: 10.539

9.  Caveolin-3 associates with developing T-tubules during muscle differentiation.

Authors:  R G Parton; M Way; N Zorzi; E Stang
Journal:  J Cell Biol       Date:  1997-01-13       Impact factor: 10.539

Review 10.  PI-loting membrane traffic.

Authors:  Maria Antonietta De Matteis; Anna Godi
Journal:  Nat Cell Biol       Date:  2004-06       Impact factor: 28.824

View more
  25 in total

1.  Dynamin GTPase regulation is altered by PH domain mutations found in centronuclear myopathy patients.

Authors:  Jon A Kenniston; Mark A Lemmon
Journal:  EMBO J       Date:  2010-08-10       Impact factor: 11.598

Review 2.  The genetics and neuropathology of Alzheimer's disease.

Authors:  Gerard D Schellenberg; Thomas J Montine
Journal:  Acta Neuropathol       Date:  2012-05-23       Impact factor: 17.088

3.  A mutation associated with centronuclear myopathy enhances the size and stability of dynamin 2 complexes in cells.

Authors:  Nicholas G James; Michelle A Digman; Justin A Ross; Barbara Barylko; Lei Wang; Jinhui Li; Yan Chen; Joachim D Mueller; Enrico Gratton; Joseph P Albanesi; David M Jameson
Journal:  Biochim Biophys Acta       Date:  2013-09-07

4.  Dynamin 2 the rescue for centronuclear myopathy.

Authors:  Alexis R Demonbreun; Elizabeth M McNally
Journal:  J Clin Invest       Date:  2014-02-24       Impact factor: 14.808

5.  Bridging integrator 1 (BIN1) protein expression increases in the Alzheimer's disease brain and correlates with neurofibrillary tangle pathology.

Authors:  Christopher J Holler; Paulina R Davis; Tina L Beckett; Thomas L Platt; Robin L Webb; Elizabeth Head; M Paul Murphy
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

6.  Alternative Splicing of Four Trafficking Genes Regulates Myofiber Structure and Skeletal Muscle Physiology.

Authors:  Jimena Giudice; James A Loehr; George G Rodney; Thomas A Cooper
Journal:  Cell Rep       Date:  2016-11-15       Impact factor: 9.423

7.  Overexpression of caveolins in Caenorhabditis elegans induces changes in egg-laying and fecundity.

Authors:  Scott Parker; Howard A Baylis
Journal:  Commun Integr Biol       Date:  2009-09

8.  VAMP2 marks quiescent satellite cells and myotubes, but not activated myoblasts.

Authors:  Yuki Tajika; Maiko Takahashi; Mizuki Hino; Tohru Murakami; Hiroshi Yorifuji
Journal:  Acta Histochem Cytochem       Date:  2010-08-03       Impact factor: 1.938

Review 9.  The early endosome: a busy sorting station for proteins at the crossroads.

Authors:  Marko Jovic; Mahak Sharma; Juliati Rahajeng; Steve Caplan
Journal:  Histol Histopathol       Date:  2010-01       Impact factor: 2.303

10.  Loss of myotubularin function results in T-tubule disorganization in zebrafish and human myotubular myopathy.

Authors:  James J Dowling; Andrew P Vreede; Sean E Low; Elizabeth M Gibbs; John Y Kuwada; Carsten G Bonnemann; Eva L Feldman
Journal:  PLoS Genet       Date:  2009-02-06       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.